The loss of one order and the winning of two new “major” ones has prompted a restructuring and plant closure for German supplier of primary packaging Gerresheimer.
The company announced 11 July that it had secured two new major contracts: one for the manufacture of inhalers and another for prefillable syringes for “a major heparin producer”.
At the same time, the company has lost “a significantly smaller order” in the inhaler business, which has resulted in a restructuring operation involving the closure of its production plant in Küssnacht, Switzerland, by the end of 2019.
And staying in Switzerland, the German medical supplier is expanding its drug delivery portfolio with the acquisition of medical device maker Sensile Medical AG.
The acquisition was made under a share purchase agreement signed 11 July, and will have a maximum purchase price of €350m, depending on “the attainment of contractually specified milestones”, said Gerresheimer.
Sensile Medical develops nanolitre-based medical devices for drug delivery and digitally-connected platforms.
The takeover, said Gerresheimer, is part of its strategy to become an OME for drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers.